Blog
Clinical trial supply overage – How to reduce product wastage in an unpredictable world?
Pharmaceutical organizations are putting more and more pressure on clinical supply chain managers to minimize study overage. Study overage represents the kits that will expire unused at the investigational sites, local depots and central depot. Some overage is absolutely needed, both as insurance against the unexpected events that can occur during the trial and as a result of the design of the protocol and distribution network.
But often the question is raised (and not only by higher management): is the requested amount of overage absolutely necessary or is it possible to decrease it?
SCOOP 4.7. released. Gerdau first to experience!
Discover the new features available in SCOOP 4.7.: Redesigned downstream model Fine-tuned ferro-allow calculation in steelmaking/refinery model Enhanced power plant model Completely new reporting tools Redesigned downstream model: The downstream model has been...
InduStore: New Research Project for Energy Optimization
Funded by the Walloon Region in the Energinsere program (energy storage), InduStore has the objective to quantify and leverage the potential of energy flexibility in industrial sites, using advanced analytic methods such as optimization. By reducing energy costs and...
Russia Major Steel Producers getting ready to maximize their profit!
Two of the largest Russian steel producers, Severstal and NLMK, have started the implementation of SCOOP, N-SIDE’s integrated technical and economical model for steel plants optimization. From raw material purchase to final product sale, taking into account process,...